Two post-surgery blood–brain disruption windows may offer glioblastoma treatment targets

MedicalXpress | juil. 29, 2026

Scientists in Britain and Spain have discovered critical windows after glioblastoma surgery when the brain's defenses falter, creating a rare chance to deliver powerful treatments exactly where needed. If doctors time treatment within two narrow postoperative windows identified by the researchers, existing lipid nanoparticle medicines—already approved and routinely used in oncology hospitals today—could be redeployed to deliver early, precision-targeted therapy to the brain.